44 related articles for article (PubMed ID: 31106694)
1. Stenting performs better than drug-coated balloon angioplasty in popliteal lesions.
Andraska E; Martinez Garcia R; Abdul Malak O; Liang N; Sridharan N; Chaer R; Avgerinos E; Salem K
J Vasc Surg; 2023 Aug; 78(2):483-489.e1. PubMed ID: 37076110
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Excimer Laser Ablation Combined with Drug-coated Balloon in Atherosclerotic Lesions of the Popliteal Artery.
Jiang X; Ju S; Liu H; Chen B; Jiang J; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Fu W; Dong Z
Ann Vasc Surg; 2024 Jul; 104():196-204. PubMed ID: 38492729
[TBL] [Abstract][Full Text] [Related]
3. A unique mechanism of restenosis after drug-coated balloon in peripheral artery: Insight from optical frequency domain imaging.
Jinnouchi H; Sakakura K; Yamamoto K; Taniguchi Y; Fujita H
Cardiovasc Revasc Med; 2024 May; 62():119-122. PubMed ID: 38114363
[TBL] [Abstract][Full Text] [Related]
4. Initial Results of Standard Balloon Angioplasty Versus Drug Coated Balloon Alone Versus in Association With Laser Excimer Atherectomy in the Treatment of Femoropopliteal Artery In Stent Restenosis (INTACT).
Ducasse E; Sapoval M; Brunet J; Goueffic Y; Lermusiaux P; Caradu C
Eur J Vasc Endovasc Surg; 2024 May; 67(5):850-851. PubMed ID: 38301872
[No Abstract] [Full Text] [Related]
5. Predicting residual pressure gradients after balloon angioplasty in patients with femoropopliteal artery lesions.
Yoshioka N; Morita Y; Shimada T; Kobayashi H; Tanikawa Y; Minamiya A; Yamada T; Morishima I
Heart Vessels; 2024 Jul; 39(7):589-596. PubMed ID: 38345632
[TBL] [Abstract][Full Text] [Related]
6. A Segmentalized Approach to Femoropopliteal Chronic Total Occlusions.
Shishehbor MH; Hammad TA
JACC Cardiovasc Interv; 2024 Mar; 17(5):619-621. PubMed ID: 38479963
[No Abstract] [Full Text] [Related]
7. Comparison of the Pre-Established and Finally Selected Treatment Strategies for Endovascular Treatment in Femoropopliteal Artery Lesions.
Higashitani M; Ueshima D; Suzuki K; Yamauchi Y; Hirokami M; Tsubakimoto Y; Takahashi A; Kato T; Ando H; Nakamura M
Int Heart J; 2024 Mar; 65(2):230-236. PubMed ID: 38479851
[TBL] [Abstract][Full Text] [Related]
8. Correlation between physiological assessment and imaging findings during drug-coated balloon treatment for femoropopliteal diseases.
Iwasaki Y; Shimada T; Sato T; Koike J; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
Cardiovasc Revasc Med; 2024 Mar; 60():66-71. PubMed ID: 37739885
[TBL] [Abstract][Full Text] [Related]
9. Effect of EDTA with porous balloon on calcified lesion: An atherosclerotic cadaver study.
Kawai K; Madra A; Kawakami R; Sato Y; Konishi T; Shiraki T; Sekimoto T; Tanaka T; Virmani R; Finn AV
Catheter Cardiovasc Interv; 2024 May; 103(6):972-981. PubMed ID: 38606477
[TBL] [Abstract][Full Text] [Related]
10. One-step solution for angioplasty, low-profile stent delivery, and intrastent dilation using a dual-lumen angioplasty balloon microcatheter: technical advances, limitations, outcomes, and literature review.
Liu P; Zhang H; Shi Y; Li Z; Liu Y; Li P; Tian Y
Neurosurg Rev; 2023 Sep; 46(1):234. PubMed ID: 37682426
[TBL] [Abstract][Full Text] [Related]
11. Plaque Morphological Changes in Femoropopliteal Arterial Lesions Caused by Balloon Angioplasty: Analysis Through Integrated Backscatter Intravascular Ultrasound.
Hayashi O; Shimada T; Fujisawa N; Yamazaki T; Izumiya Y; Fukuda D
Eur J Vasc Endovasc Surg; 2024 Feb; ():. PubMed ID: 38342403
[No Abstract] [Full Text] [Related]
12. Bailout angioplasty or stenting for large vessel occlusion.
Roy JM; Tjoumakaris S
Lancet Neurol; 2024 Jun; ():. PubMed ID: 38914086
[No Abstract] [Full Text] [Related]
13. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
[No Abstract] [Full Text] [Related]
14. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
[TBL] [Abstract][Full Text] [Related]
15. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
16. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
[TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
Herten M; Torsello GB; Schönefeld E; Stahlhoff S
Vasc Health Risk Manag; 2016; 12():341-56. PubMed ID: 27621646
[TBL] [Abstract][Full Text] [Related]
18. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
Zeller T; Lopez L; Pigott JP
J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
